Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Anemia Drugs News Monitoring

Get by Email • RSS

Published on Apr 28, 2025

Baby Your Baby- New Study to Reduce the Need for Blood Transfusions in Premature Babies

A new study published in the Journal of Perinatology is helping premature babies avoid blood transfusions, thanks to new research and collaboration between researchers at Intermountain Health and the University of Utah. Timothy Bahr, MD, an Intermountain …

Source: KUTV - Utah - Center-right
Published on Apr 28, 2025

Hepatitis C Rates Decreased by 30% Among Alaskan Adults

Annual chronic hepatitis C (HCV) cases among adults in Alaska significantly declined between 2016 and 2023 but remain high among certain groups, according to the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR …

Source: Hep - Pending
Published on Apr 28, 2025

Does Metformin Cause Hair Loss?

dragana991 / iStockMetformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the connection might not be what you think. So, does metformin cause hair loss? We have answers. …

Source: AOL - Pending
Published on Apr 28, 2025

Gene circuits enable more precise control of gene therapy

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene therapy treatments that could cure such diseases by delivering a new copy of the missing genes to the affected cells. Despite those …

Source: MIT - Neutral
Published on Apr 28, 2025

Zongertinib Yields Clinical Benefit in Previously Treated, HER2-Mutated, Advanced NSCLC

Treatment with zongertinib (BI 1810631) generated responses patients with previously treated advanced non–small cell lung cancer (NSCLC) harboring HER2 mutations, according to data from the phase 1a/b Beamion LUNG-1 trial (NCT04886804) presented at the …

Source: OncLive - Pending
Published on Apr 28, 2025

Linvoseltamab Receives EC Approval for Heavily Pretreated R/R Myeloma

The European Commission (EC) has granted conditional marketing authorization to linvoseltamab (Lynozyfic) for the treatment of adult patients with relapsed/refractory multiple myeloma who have received at least 3 prior therapies, including a proteasome …

Source: OncLive - Pending
Published on Apr 28, 2025

Regeneron scores EU nod for bispecific antibody Lynozyfic, setting up clash with J&J and Pfizer

After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody linvoseltamab, the company has crossed the regulatory finish line with its new drug in Europe. The European Commission has approved …

Source: Fierce Pharma - Neutral
Published on Apr 28, 2025

India's Malaria Elimination Strategy: Digital Health, AAMs and Genetic Innovation

New Delhi: India is at a critical juncture in its mission to eliminate malaria, with tribal and hard-to-reach regions posing the final and toughest challenge. In an insightful conversation, Dr. Sita Rama Budaraja, Advisor, Health, Tata Trusts, discusses …

Source: ETHealthworld.com - Center-right
Published on Apr 28, 2025

Raisin Water: The Simple Morning Drink With 8 Powerful Health Perks

Raisins, the sweet and chewy dried form of grapes, are packed with nutrients. But soaking them overnight and drinking the water they steep in can boost their health benefits even further. Soaked raisin water is an age-old remedy used in traditional …

Source: Zee News - Right-wing
Published on Apr 28, 2025

Does Vitamin D Deficiency Cause Hair Lοss? Myths & Truth

If you’re shedding more hair than usual, you might be wondering, “Does vitamin D deficiency cause hair loss?” We'll explore the connection between the two to see how the sunshine vitamin affects your hair health. Then, we’ll peek at some popular …

Source: Orlando Weekly - Florida - Left-wing
Published on Apr 28, 2025

Off-the-Shelf CAR Natural Killer Cell Therapy Elicits Leukemia Remission

Off-the-Shelf CAR Natural Killer Cell Therapy with Logic Gates Elicits Complete Remissions in Relapsed or Refractory Blood Cancers Several patients with acute myeloid leukemia (AML), who were treated with SENTI-202, a first-in-class chimeric antigen …

Source: Cancer Health - Pending
Published on Apr 28, 2025

Olaparib Plus Pembrolizumab Shows Efficacy in HRR Gene–Mutated Advanced Tumors With/Without HRD Positivity

Olaparib Plus Pembrolizumab in HRR Gene–Mutated Tumors | Image Credit: © Kellie Ehrmann/ MJH Life Sciences Using AI Olaparib (Lynparza) in combination with pembrolizumab (Keytruda) showed promising activity in patients with homologous recombination …

Source: OncLive - Pending
Published on Apr 28, 2025

Perioperative Pembrolizumab Poses a New Standard of Care Option in Resectable, Locally Advanced HNSCC

The combination of neoadjuvant pembrolizumab (Keytruda) followed by surgery and adjuvant pembrolizumab with and after postoperative radiation with or without cisplatin represents a new standard of care (SOC) for the treatment of patients with resectable …

Source: OncLive - Pending
Published on Apr 27, 2025

AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML

Interim results from the phase 1 SENTI-202-101 clinical trial (NCT06325748) investigating SENTI-202 (Senti Biosciences), a first-in-class off-the-shelf chimeric antigen receptor natural killer (CAR NK) cell therapy, were presented at the 2025 American …

Source: Pharmacy Times - Neutral
Published on Apr 27, 2025

Erythropoietin does not reduce deaths among infants with birth asphyxia

April 27, 2025 2 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: High-dose …

Source: Healio News - Neutral
Published on Apr 28, 2025

Predictive Factors for Fetal Growth Restriction in Patients with Preeclampsia: A Clinical Prediction Study

Introduction Preeclampsia (PE) is a common complication during pregnancy characterized by the onset of high blood pressure and proteinuria, usually occurring after 20 weeks of gestation.1 PE significantly contributes to maternal and perinatal morbidity and …

Source: Dove Medical Press - Neutral
Published on Apr 28, 2025

Dementia, Systemic Biomarkers, and Risk of 30-Day Readmission After Pneumonia: A Multi-Center Cohort Study

Introduction Dementia, a progressive neurodegenerative condition, poses an escalating public health challenge, with its global prevalence expected to triple by 2050.1 This condition significantly burdens healthcare systems due to its associations with …

Source: Dove Medical Press - Neutral
Published on Apr 28, 2025

4-Octyl Itaconate Modulates Dendritic Cells Function and Tumor Immunity via NRF2 Activation

Introduction Dendritic cells (DCs) serve as specialized antigen-presenting cells that are key to integrating innate and adaptive immunity.1,2 DCs play a critical role in initiating specific T cell-mediated anti-tumor immune responses by cross-presenting …

Source: Dove Medical Press - Neutral
Published on Apr 24, 2025

Blocking key immune regulator eradicates liver tumors in mice

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening the immune system’s response to cancer. Blocking the activity of the protein turns formerly “cold,” or …

Source: Stanford News - California - Neutral

03 days 17:56:32

Featured Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 06:30 GMT

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2025. The full report can be found here. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 2, 2025 - 02:56 GMT

OBI Pharma gibt bekannt, dass die US-Arzneimittelbehörde FDA den IND-Antrag für eine Phase-1/2-Studie mit OBI-902, einem ...

TAIPEI, Taiwan, May 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. („OBI“), ein Onkologieunternehmen in der klinischen Phase (4174.TWO), hat heute bekannt gegeben, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) den Antrag …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 2, 2025 - 02:56 GMT

OBI Pharma reçoit l’approbation de la FDA à la suite de sa demande d’étude clinique de la Phase I/II pour OBI-902, un ...

TAIPEI, Taïwan, 02 mai 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (« OBI »), un laboratoire d’oncologie au stade clinique (4174.TWO), annonce ce jour que l’Agence américaine des produits alimentaires et médicamenteux, la Food and Drug Administration, ou « …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 21:00 GMT

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on May 1, 2025 - 20:30 GMT

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …

Distribution channels:
Published on May 1, 2025 - 22:21 GMT

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before ...

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on May 1, 2025 - 20:15 GMT

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 20:01 GMT

Ascendis Pharma Reports First Quarter 2025 Financial Results

- Q1 2025 revenue of €44.7 million for YORVIPATH® and €51.3 million for SKYTROFA® - TransCon™ CNP NDA submitted in Q1 2025; MAA submission planned in Q3 2025 - Topline COACH combination trial (TransCon CNP + TransCon hGH) data expected in Q2 2025 - …

Distribution channels:

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 808,800,632 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 08:05 GMT

Celebrating One Year of 5-Star Urgent Care Services in Clear Lake, Houston

HOUSTON, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Priority Urgent Care and Walk-In Clinic - Clear Lake proudly celebrates its one-year anniversary of delivering exceptional, patient-centered urgent care services in Clear Lake, with a …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on May 2, 2025 - 07:47 GMT

PowerDMARC is an Official Sponsor of MSPGeekCon 2025 in Orlando

ORLANDO, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- PowerDMARC, a global leader in email authentication and DMARC management solutions, is excited to announce its sponsorship and participation at MSPGeekCon 2025, taking place May 4–6 at …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:39 GMT

Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI

Emerging trends in AI-based skin assessment, rising preference for plant-based solutions, and expansion of medical-grade skincare to drive 9.0% CAGR growth NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global hyperpigmentation …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:23 GMT

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The hidradenitis suppurativa …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:14 GMT

Drowning is the leading cause of death children ages 1-4

Drowning is a serious issue, how to become safer in, on, or near the water. NEW YORK, NY, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Drowning is the leading cause of death for children ages 1-4 May is National Water Safety Awareness …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 2, 2025 - 05:13 GMT

Qualiphy Simplifies Good Faith Exams for Medical Spas and Clinics

BEVERLY HILLS, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- In response to growing demand for compliant, accessible healthcare solutions, Qualiphy has launched a turnkey telehealth infrastructure for aesthetic clinics, medical spas, and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:04 GMT

WeaponUP Now Accepts HSA/FSA Payments Through Flex

MIAMI, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- WeaponUP, the digital sword-yoga fusion platform, is proud to announce its new partnership with Flex, enabling customers to use their Health Savings Account (HSA) or Flexible Spending …

Distribution channels: Business & Economy, Gifts, Games & Hobbies ...
Published on May 2, 2025 - 04:34 GMT

Health City Robotic Surgery Transforms the Lives of Fibroid Patients

CAYMAN ISLANDS, May 1, 2025 /⁨EINPresswire.com⁩/ -- After more than a decade of living with pain and complications from uterine fibroids, a Caribbean woman has found relief through robotic-assisted surgery at Health City Cayman Islands. Ayanna, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 22:03 GMT

Tiller-Hewitt Launches New Growth Solutions for Healthcare Systems

Expanded suite addresses physician alignment, strategic growth, and network optimization amid industry-wide transformation. ST. LOUIS, MO, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- As healthcare organizations continue to face workforce …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 1, 2025 - 21:30 GMT

Venture Medical Announces Strategic Partnership with Plasmacure to Bring Cold Plasma Therapy System to the U.S. Market

Proven cold plasma therapy system for chronic wound treatment represents patient-first innovation. MISSOULA, MT, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Venture Medical, LLC, a leading provider of advanced wound care solutions, is proud …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 09:17 GMT

Best Anti-Snoring Devices: Stop Snoring Immediately. New Report Reveals Which Devices Actually Work.

New York, May 02, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted resource for product research and rankings, has officially released its list of the best anti-snoring devices, spotlighting three standout products designed to help individuals reduce snoring …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Hilpi Rautelin

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Kari Jussi Aho

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Kari Jussi Aho Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Maziar Mike Doustdar Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar

ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Ari Lehtoranta

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...